Business Description
Liquidia Corp
NAICS : 325414
SIC : 2836
ISIN : US53635D2027
Share Class Description:
LQDA: Ordinary SharesTotal Employee Number:
216Compare
Compare
Traded in other countries / regions
LQDA.USALT4.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2018-07-26Description
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.21 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 1.7 | |||||
Debt-to-EBITDA | 3.44 | |||||
Interest Coverage | 1.75 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 13.38 | |||||
Beneish M-Score | 16.27 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 91.7 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | -6.9 | |||||
3-Year FCF Growth Rate | -0.6 | |||||
3-Year Book Growth Rate | -28.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 99.62 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 57.19 | |||||
9-Day RSI | 63.97 | |||||
14-Day RSI | 66.51 | |||||
3-1 Month Momentum % | 63.49 | |||||
6-1 Month Momentum % | 78.89 | |||||
12-1 Month Momentum % | 395.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.22 | |||||
Quick Ratio | 2.03 | |||||
Cash Ratio | 1.49 | |||||
Days Inventory | 262.05 | |||||
Days Sales Outstanding | 44.46 | |||||
Days Payable | 126.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.6 | |||||
Shareholder Yield % | -1.9 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 91.82 | |||||
Operating Margin % | 15.81 | |||||
Net Margin % | 7.74 | |||||
EBITDA Margin % | 18.68 | |||||
FCF Margin % | 13.59 | |||||
OCF Margin % | 16.66 | |||||
ROE % | 46.41 | |||||
ROA % | 7.48 | |||||
ROIC % | 33.38 | |||||
3-Year ROIIC % | -12.55 | |||||
ROC (Joel Greenblatt) % | 213.84 | |||||
ROCE % | 27.12 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 569.5 | |||||
Forward PE Ratio | 23.81 | |||||
PE Ratio without NRI | 569.5 | |||||
PEG Ratio | 80.21 | |||||
PS Ratio | 25.67 | |||||
PB Ratio | 64.82 | |||||
Price-to-Tangible-Book | 69.33 | |||||
Price-to-Free-Cash-Flow | 222.11 | |||||
Price-to-Operating-Cash-Flow | 174.07 | |||||
EV-to-EBIT | 135.05 | |||||
EV-to-EBITDA | 131.1 | |||||
EV-to-Revenue | 24.48 | |||||
EV-to-Forward-Revenue | 11.54 | |||||
EV-to-FCF | 180.15 | |||||
Price-to-GF-Value | 0.36 | |||||
Price-to-Graham-Number | 41.74 | |||||
| Price-to-Net-Current-Asset-Value | 177.18 | |||||
Earnings Yield (Greenblatt) % | 0.74 | |||||
FCF Yield % | 0.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LQDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Liquidia Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 288.065 | ||
| EPS (TTM) ($) | 0.14 | ||
| Beta | 0.9749 | ||
| 3-Year Sharpe Ratio | 1.18 | ||
| 3-Year Sortino Ratio | 3.19 | ||
| Volatility % | 97.22 | ||
| 14-Day RSI | 66.51 | ||
| 14-Day ATR ($) | 4.299577 | ||
| 20-Day SMA ($) | 68.24 | ||
| 12-1 Month Momentum % | 395.18 | ||
| 52-Week Range ($) | 11.85 - 80.69 | ||
| Shares Outstanding (Mil) | 88.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Liquidia Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Liquidia Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-03 08:30 | In 126 days | ||
| Third quarter earnings results for 2026 | 2026-11-03 | In 125 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-12 08:30 | In 43 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 42 days | ||
| General meeting for 2026 | 2026-06-16 16:30 | 71.80 (-1.12%) | ||
| Guidance call for 2026 | 2026-06-03 12:45 | 55.11 (-5.27%) | ||
| H.C. Wainwright 4(th) Annual Bioconnect Investor Conference at NASDAQ | 2026-05-19 09:30 | 56.97 (-1.53%) | ||
| Guidance call for 2026 | 2026-05-13 08:40 | 56.60 (+5.20%) | ||
| First quarter earnings conference call for 2026 | 2026-05-11 08:30 | 42.30 (+0.62%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 42.30 (+0.62%) |
Show
Entries
Liquidia Corp Frequently Asked Questions
What is Liquidia Corp(LQDA)'s stock price today?
The current price of LQDA is $79.72. The 52 week high of LQDA is $80.69 and 52 week low is $11.85.
When is next earnings date of Liquidia Corp(LQDA)?
The next earnings date of Liquidia Corp(LQDA) is 2026-08-12 Est..
Does Liquidia Corp(LQDA) pay dividends? If so, how much?
Liquidia Corp(LQDA) does not pay dividend.
Guru Commentaries on NAS:LQDA
No articles.
Press Release
Articles on Liquidia Corp
No articles.
Headlines
See More- 1
Jun 17, 2026
Board Member At Liquidia Sells $14.01M Of Stock
Benzinga • 10:02am
Jun 11, 2026
Insider Selling: Stephen M Bloch Unloads $14.27M Of Liquidia Stock
Benzinga • 10:03am
Jun 04, 2026
Amarin dealt blow as Supreme Court upholds 'skinny labels' for generics
Seeking Alpha • 12:46pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers